beta-thujaplicin has been researched along with Atherogenesis in 1 studies
beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.
Excerpt | Relevance | Reference |
---|---|---|
"The progression of atherosclerosis is linked to proliferation and migration of vascular smooth muscle cell via MMP-2 and MMP-9 activities." | 1.48 | Treatment of β-thujaplicin counteracts di(2-ethylhexyl)phthalate (DEHP)-exposed vascular smooth muscle activation, inflammation and atherosclerosis progression. ( Cherng, JY; Liu, CC; Pan, KH; Shen, CR; Shih, MF, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shih, MF | 1 |
Pan, KH | 1 |
Liu, CC | 1 |
Shen, CR | 1 |
Cherng, JY | 1 |
1 other study available for beta-thujaplicin and Atherogenesis
Article | Year |
---|---|
Treatment of β-thujaplicin counteracts di(2-ethylhexyl)phthalate (DEHP)-exposed vascular smooth muscle activation, inflammation and atherosclerosis progression.
Topics: Animals; Atherosclerosis; Cell Line; Diethylhexyl Phthalate; Disease Progression; E-Selectin; Endoth | 2018 |